chr1-196779305-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021023.6(CFHR3):c.202G>A(p.Asp68Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000085 in 1,529,428 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021023.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR3 | NM_021023.6 | c.202G>A | p.Asp68Asn | missense_variant | 2/6 | ENST00000367425.9 | |
CFHR3 | NM_001166624.2 | c.202G>A | p.Asp68Asn | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR3 | ENST00000367425.9 | c.202G>A | p.Asp68Asn | missense_variant | 2/6 | 1 | NM_021023.6 | P1 | |
CFHR3 | ENST00000471440.6 | c.202G>A | p.Asp68Asn | missense_variant | 2/5 | 1 | |||
CFHR3 | ENST00000391985.7 | c.202G>A | p.Asp68Asn | missense_variant | 2/5 | 2 | |||
CFHR3 | ENST00000367427.7 | c.202G>A | p.Asp68Asn | missense_variant, NMD_transcript_variant | 2/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000220 AC: 3AN: 136310Hom.: 1 Cov.: 25
GnomAD3 exomes AF: 0.00000419 AC: 1AN: 238442Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 128568
GnomAD4 exome AF: 0.00000718 AC: 10AN: 1393118Hom.: 2 Cov.: 30 AF XY: 0.00000578 AC XY: 4AN XY: 691878
GnomAD4 genome AF: 0.0000220 AC: 3AN: 136310Hom.: 1 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 66296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2024 | The c.202G>A (p.D68N) alteration is located in exon 2 (coding exon 2) of the CFHR3 gene. This alteration results from a G to A substitution at nucleotide position 202, causing the aspartic acid (D) at amino acid position 68 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at